Physician profile
Alan Greenberg
NPI 1184392763
$1,947.10
in general payments reported to CMS, 2019-2025
14 companies · $387 in 2025
The $387 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $489 · 2022: $329 · 2023: $377 · 2024: $365 · 2025: $387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,129.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $680.61 | 2023-2025 | Total30, Precision 1, Dailies |
| Eyevance Pharmaceuticals LLC | $245.80 | 2021 | |
| Coopervision INC. | $192.98 | 2023-2025 | Clariti Contact Lens, Myday Contact Lens |
| Bausch & Lomb Americas INC. | $165.25 | 2025 | Miebo, Xiidra, Infuse |
| Dompe US, INC. | $136.49 | 2021-2024 | Oxervate |
| Sight Sciences, INC. | $133.09 | 2022 | |
| Aerie Pharmaceuticals, INC. | $125.00 | 2021 | |
| Oyster Point Pharma, INC. | $116.64 | 2022-2023 | Tyrvaya |
| Visioneering Technologies, INC. | $34.52 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $26.46 | 2024 | Xdemvy |
| Beaver-Visitec International, INC. | $24.37 | 2022 | |
| Alexion Pharmaceuticals, INC. | $24.00 | 2022 | |
| Sun Pharmaceutical Industries INC. | $21.08 | 2022 | |
| Abbvie INC. | $20.81 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Greenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.